Literature DB >> 26489943

Byssinosis and COPD rates among factory workers manufacturing hemp and jute.

Mukremin Er1, Salih A Emri2, Ahmet U Demir3, Peter S Thorne4, Yalcin Karakoca5, Nazmi Bilir6, Izzettin Y Baris7.   

Abstract

OBJECTIVES: Prior studies have been performed on cotton textile plants throughout the world. This study was planned to identify the rate of byssinosis and chronic obstructive pulmonary disease (COPD) in hemp and jute workers and those who worked with both of them.
MATERIAL AND METHODS: The study was realized in a factory which consecutively processed hemp and jute. The study enrollment included 266 people, 164 of whom were active workers and 102 were retired. A questionnaire, plain chest X-rays, physical examination and pulmonary function tests were performed. Dust levels were measured in various sections of the factory during 8 h work shifts. Endotoxin levels of various quality hemp fibers and dusts were measured.
RESULTS: The rate of byssinosis (28.2%) was higher among the workers that who exposed to both jute and hemp dust. The frequency of chronic bronchitis in retired workers who previously smoked was higher (20%) as compared to currently smoking workers (17%). High dust levels were measured in some parts of the factory (mean (M) = 2.69 mg/m3). Working in dense dust areas, active smoking, being older than 40 years of age, being an ex-smoker, and working in the factory for a period exceeding 15 years were significantly associated with bronchitis and emphysema development. High endotoxin levels were determined for fine hemp dust (605 EU/mg), coarse hemp dust (336 EU/mg) and poor quality hemp fibers (114 EU/mg), whereas in fresh hemp stalks the level of endotoxin was determined to be lower (0.27 EU/mg).
CONCLUSIONS: Because of high exposures to jute and hemp dusts that are associated with high byssinosis rates, personal protection and environmental hygiene is crucial to prevention of byssinosis. This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Entities:  

Keywords:  COPD; byssinosis; endotoxin; hemp; jute; occupational health

Mesh:

Substances:

Year:  2016        PMID: 26489943     DOI: 10.13075/ijomeh.1896.00512

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  5 in total

Review 1.  Occupational Allergies to Cannabis.

Authors:  Ine I Decuyper; Brett J Green; Gordon L Sussman; Didier G Ebo; William S Silvers; Karin Pacheco; Bradley S King; John R Cohn; Robert S Zeiger; Joanna S Zeiger; David R Naimi; Donald H Beezhold; Ajay P Nayak
Journal:  J Allergy Clin Immunol Pract       Date:  2020 Nov - Dec

2.  Cannabis: An Emerging Occupational Allergen?

Authors:  Gordon L Sussman; Donald H Beezhold; John R Cohn; William S Silvers; Joanna S Zeiger; Ajay P Nayak
Journal:  Ann Work Expo Health       Date:  2020-08-06       Impact factor: 2.179

3.  Microbial hazards during harvesting and processing at an outdoor United States cannabis farm.

Authors:  Brett J Green; James R Couch; Angela R Lemons; Nancy C Burton; Kerton R Victory; Ajay P Nayak; Donald H Beezhold
Journal:  J Occup Environ Hyg       Date:  2018-05       Impact factor: 2.155

4.  Allergic and Respiratory Symptoms in Employees of Indoor Cannabis Grow Facilities.

Authors:  Coralynn Sack; Niloufar Ghodsian; Karen Jansen; Brynne Silvey; Christopher D Simpson
Journal:  Ann Work Expo Health       Date:  2020-08-06       Impact factor: 2.779

5.  American Epilepsy Society (AES): Written Comments to Norman E. "Ned" Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019.

Authors:  Timothy E Welty; Kevin E Chapman; R Edward Faught; Robert J Kotloski
Journal:  Epilepsy Curr       Date:  2019-10-22       Impact factor: 7.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.